Jennifer A. Martin

Eli Lilly (United States) — United States

Medicine · Health Sciences

23h-index1.5kcitations55works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(9), Neurotransmitter Receptor Influence on Behavior(8), Receptor Mechanisms and Signaling(7), Neuropeptides and Animal Physiology(5), Epigenetics and DNA Methylation(4)

Publications55 total

Controlling Gastric Delivery of a GIP/GLP1 Peptide in Monkeys by Mucoadhesive SNAC Tablets
Pharmaceutical Research·2025· 2 cited
Characterization of LY3324954 a long-acting glucagon-receptor agonist
Molecular Metabolism·2024· 5 citedOpen Access
Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys
European Journal of Pharmaceutical Sciences·2024· 9 citedOpen Access
A Novel Role for the Histone Demethylase JMJD3 in Mediating Heroin-Induced Relapse-Like Behaviors
Biological Psychiatry·2024· 4 cited
The Digital Life-space as a Practice Setting
2024
A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases
JCI Insight·2023· 13 citedOpen Access
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Cell Metabolism·2023· 87 cited
EGR3 regulates opioid-related nociception and motivation in male rats
Psychopharmacology·2022· 3 citedOpen Access
Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
Diabetes Obesity and Metabolism·2022· 40 citedOpen Access
Pharmacological Evaluation of a Pegylated Urocortin-1 Peptide in Experimental Autoimmune Disease Models
Journal of Pharmacology and Experimental Therapeutics·2022· 1 citedOpen Access
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Clinical Pharmacokinetics·2022· 27 citedOpen Access
A convergent mechanism of high risk factors <i>ADNP</i> and <i>POGZ</i> in neurodevelopmental disorders
Brain·2022· 28 citedOpen Access
CLUSTERING AND DIMENSIONAL REDUCTION FOR VISUALIZING KNEE OSTEOARTHRITIS PHENOTYPES: DATA FROM THE OAI
Osteoarthritis and Cartilage·2022· 1 cited
Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats
Neuropsychopharmacology·2022· 36 citedOpen Access
Integrated Digital Health System Tools to Support Decision Making and Treatment Preparation in CKD: The PREPARE NOW StudyPlain-Language Summary
Kidney Medicine·2021Open Access
Integrated Digital Health System Tools to Support Decision Making and Treatment Preparation in CKD: The PREPARE NOW Study
Kidney Medicine·2021· 21 citedOpen Access
Renal Impairment Has No Impact on the Clinical Pharmacokinetics of Tirzepatide
Diabetologie und Stoffwechsel·2021· 3 cited
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
Clinical Pharmacokinetics·2021· 56 citedOpen Access
Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced maladaptive plasticity
2021Open Access
A role for the endocannabinoid enzymes monoacylglycerol and diacylglycerol lipases in cue‐induced cocaine craving following prolonged abstinence
Addiction Biology·2021· 20 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

David Dietz(16), Craig Werner(11), Swarup Mitra(10), Amy M. Gancarz(10), Andrew F. Stewart(7), Rachael L. Neve(7), Zi-Jun Wang(6), Pedro H. Gobira(6), Ian Maze(5), Shruthi A. Thomas(5), Ashley E. Lepack(4), Ramesh Chandra(4), Mary Kay Lobo(4), Aaron Caccamise(4), Shweta Urva(4), Jun‐Xu Li(4), Patti L. Ephraim(4), Sarah B. Peskoe(4), Jane Pendergast(4), Christoph Hauer(4)